https://www.jnj.com/media-center/press-releases/u-s-fda-approves-streamlined-process-for-initiating-hiv-therapy-with-cabenuva-cabotegravir-and-rilpivirine-the-first-and-only-complete-long-acting-injectable-hiv-treatment
Adults living with HIV now have an option to start injectable regimen without the need for an oral lead-in period first
u shiv therapyfdastreamlinedprocess